{"protocolSection":{"identificationModule":{"nctId":"NCT06220981","orgStudyIdInfo":{"id":"2015-17637"},"organization":{"fullName":"Oslo University Hospital","class":"OTHER"},"briefTitle":"The Oslo Acute Reperfusion Stroke Study (OSCAR)","officialTitle":"The Oslo Acute Reperfusion Stroke Study (OSCAR)","acronym":"OSCAR"},"statusModule":{"statusVerifiedDate":"2024-01","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-01-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-01-14","studyFirstSubmitQcDate":"2024-01-23","studyFirstPostDateStruct":{"date":"2024-01-24","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-01-23","lastUpdatePostDateStruct":{"date":"2024-01-24","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Anne Hege Aamodt","investigatorTitle":"Ass. Prof.","investigatorAffiliation":"Oslo University Hospital"},"leadSponsor":{"name":"Oslo University Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"1 Year","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":1500,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"OTHER","name":"Endovascular treatment"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Modified Rankin Scale Score","description":"Modified Rankin Scale Score (mRS), min 0, max 6","timeFrame":"3 months"}],"secondaryOutcomes":[{"measure":"National Institute of Health Stroke Scale Score","description":"National Institute of Health Stroke Scale Score (NIHSS, min 0, max 42)","timeFrame":"discharge"},{"measure":"Death due to any cause","description":"Mortality","timeFrame":"3 months"},{"measure":"Infarct volume","description":"Infarct volume (ml)","timeFrame":"1 day"},{"measure":"Incidence of symptomatic intracranial hemorrhage","description":"Incidence of symptomatic intracranial hemorrhage (SICH)","timeFrame":"1 day"},{"measure":"Volume of new areas of diffusion restriction","description":"Volume of new areas of diffusion restriction","timeFrame":"1 day"},{"measure":"serious adverse events","description":"serious adverse events","timeFrame":"3 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18 years or older\n* Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization.\n* All stroke severities and vascular distributions are eligible.\n* Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.\n\nExclusion criteria:\n\n• Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).","sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"acute ischemic stroke patients with proximal cerebral artery occlusion admitted for endovascular treatment.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Anne Hege Aamodt","role":"CONTACT","phone":"97417734","email":"anne.hege.aamodt@gmail.com"},{"name":"Brian Enriquez","role":"CONTACT","email":"brienr@ous-hf.no"}],"locations":[{"facility":"Oslo University Hospital","status":"RECRUITING","city":"Oslo","country":"Norway","contacts":[{"name":"Anne Hege Aamodt, MD PhD Prof","role":"CONTACT","phone":"+47 23 07 00 00","email":"anhaam@ous-hf.no"},{"name":"Brian Enriquez, MD","role":"CONTACT","phone":"+47 23 07 00 00","email":"brienr@ous-hf.no"},{"name":"Thor H Skattør, MD PhD","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":59.91273,"lon":10.74609}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Acute Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}